The study protocol was modified to include the new influenza virus, permitting the collection of the data needed to show not only increased risk of worse clinical outcomes, but of influenza infection itself. This finding strengthens the recommendations of the Advisory Committee on Immunization Practices (ACIP), the National Asthma Education and Prevention Program (NAEPP), and CDC for routine influenza vaccination among persons with asthma.
The authors were not able to demonstrate the cause of the increased risk of infections; hypotheses include altered immune status related to asthma, lessened local cell-mediated immune response from inhaled corticosteroids (which, however, remain the bedrock of most asthma care, and good asthma control going into cold & flu season is essential for this population), co-infections or other comorbidities, among other possibilities. Why had data from previous studies not been able to demonstrate this finding? Most previous data on influenza vaccination is obtained by retrospective report, such as in the Behavioral Risk Factor Surveillance System (BRFSS) and the National Health Interview Survey (NHIS). Of course, a prospective study that involved withholding vaccination would be unethical. Although an increased number of health-care visits is associated with increased likelihood of vaccination, the same data more starkly demonstrate the missed opportunities for vaccination: even among persons with asthma who had ≥ 10 health-care visits during the influenza vaccination season, only 50% received the seasonal vaccination in 2005-06 (4). A similar study using the BRFSS dataset for the 2006-07 found that among adults with asthma, only 39.9% received the influenza vaccine. People with asthma who had an increased likelihood of vaccination were aged 50-64 years, female, non-Hispanic white, and had diabetes, activity limitations, medical insurance, a regular medical care provider, routine checkup in the previous year, and formerly smoked or never smoked. Additionally, the 2009 H1N1 vaccination coverage among adults with asthma was only 25.5% (5).
Although the authors in the current study answer an important, previously unanswered question, the essential question remains: why are persons with asthma not receiving flu shots? Even more broadly, why are persons with asthma not on treatment programs consistent with the NAEPP EPR-3 guidelines? When the most recent version of the guidelines was published in 2007, the NAEPP provided the following guidance: The Expert (6) . To be consistent with the ACIP, these guidelines should be strengthened to recommend influenza vaccination for all patients with asthma because they are at increased risk for complications from asthma. Nevertheless, recommendations for influenza vaccine and other key recommendations, such as "inhaled corticosteroids are the most effective anti-inflammatory medications for long-term management of persistent asthma," and "all people with asthma should receive a written Asthma Action Plan," have similarly low uptake among patients with asthma.
Panel recommends that clinicians consider inactivated influenza vaccination for patients who have asthma. It is safe to administer in children over 6 months and adults who have asthma (Evidence A), and the Advisory Committee on Immunization Practices of the CDC recommends the vaccine for persons who have asthma because they may be at increased risk for complications from influenza
The concept of translational research-moving bench science to bedside-must go hand-inhand with translational public health, i.e., moving evidence-based guidelines into routine practice. Kloepfer and co-authors add to the evidence supporting influenza vaccination of children with asthma; we now need to routinely provide influenza vaccination to our patients with asthma. Persons with asthma are recommended to have routine follow-up visits at 1 to 6 month intervals to ensure that control of asthma is maintained. These follow-up physician visits can provide important opportunities for physicians to vaccinate persons with asthma or to remind them that they need to get an influenza vaccination. Additionally, offering influenza vaccination in the emergency room (ER) to those with asthma would be appropriate. Sometimes that is the only place these patients are seen.
